Study Links Regular Low‑Calorie Sweetener Use to Faster Memory Decline in Middle‑Aged Adults

A study published this month in the journal Neurology found that adults who regularly consumed low‑calorie and no‑calorie sweeteners experienced faster declines in memory and thinking skills over an eight‑year period, compared with non‑users. Researchers tracked diet and cognitive performance in more than 12,700 adults in Brazil, testing participants at four years and again at eight years.

In adults younger than 60, regular sweetener use was associated with cognitive decline equivalent to about 1.6 additional years of brain ageing across the eight‑year follow‑up. The pattern among participants aged 60 and older was similar but the association did not reach the same level of statistical strength. The study also reported that people with diabetes who used sweeteners had approximately a 30% higher risk of memory decline than diabetic non‑users.

The authors described their work as observational, and they did not claim to establish causation. Trade groups representing the sweetener industry responded by emphasising that observational studies cannot prove that sweeteners caused the cognitive changes, and noted that regulatory bodies in the United Kingdom, European Union and United States have previously deemed approved sweeteners safe.

The Neurology findings have renewed debate about potential long‑term effects of artificial and non‑nutritive sweeteners, which are found in diet sodas, sugar‑free yoghurts, chewing gum, sauces and some medicines. Commentators including Professor Rob Galloway, who wrote about the study in a national newspaper, said the results convinced him to remove artificially sweetened products from his household shopping and attempt to limit his children's exposure.

Researchers and clinicians point to several biologically plausible pathways that could link sweetener consumption to changes in metabolism and brain health. One proposed route is via the gut microbiome: laboratory and small human studies have shown that sweeteners such as saccharin and sucralose can alter the composition of gut bacteria, and those changes have been tied to altered glucose handling.

A 2014 trial published in the journal Nature reported that healthy volunteers given saccharin developed poorer blood‑sugar control within a week, a result that has been cited in discussions of sweeteners' metabolic effects. Other studies have suggested that some sweeteners may affect insulin sensitivity or lead to higher insulin concentrations, which over time can damage blood vessels, reduce energy supply to neurons and accelerate processes linked to cognitive decline.

Animal research has also suggested that the intensely sweet taste delivered without calories may disrupt brain signalling related to appetite and reward, and chronic over‑activation of those pathways has been associated with changes in neurotransmitters that influence memory and cognition. Inflammation and other metabolic effects have been proposed as additional mechanisms.

Experts emphasise that the new Neurology paper fills a gap in long‑term outcome data for sweeteners. Regulatory assessments of sweetener safety historically have relied largely on toxicology and short‑term studies focused on digestion and excretion, not on extended cognitive outcomes. That limitation has been a recurring theme in nutrition research, where long‑duration randomised trials on potentially harmful exposures are often infeasible or unethical.

Opponents of strong interpretation of the finding note the limits of observational research, including potential confounding factors such as overall diet quality, health behaviours and underlying conditions that could influence both sweetener use and cognitive decline. The study controlled for a range of variables, but residual confounding cannot be fully excluded.

Public health implications remain unsettled. Authors of the Neurology study and commentators recommend caution about routine, long‑term consumption of products sweetened with low‑ or no‑calorie compounds, especially among people with diabetes. At the same time, they note that occasional consumption of artificially sweetened foods and drinks is unlikely to carry the same level of risk as regular use.

The debate over sweeteners mirrors past public health controversies in which observational evidence preceded broad changes in behaviour and policy, proponents say. Critics urge continued investigation, including mechanistic studies and long‑term observational work in diverse populations, to better define any causal links and to guide advice from health authorities.

Until more definitive data are available, clinicians and public health bodies are likely to balance the Neurology findings against prior safety assessments and the metabolic risks associated with sugar. Some experts counsel reducing intake of ultra‑processed foods and beverages, emphasising water and whole foods as primary sources of hydration and nutrition, while calling for further research on the cognitive effects of habitual sweetener consumption.